Increased parathyroid hormone (PTH) is commonly associated with obesity, and its role in the pathogenesis of obesity-related glucometabolic abnormalities is uncertain. We aimed to explore the relationships of PTH with glucose/insulin homeostasis parameters before and after bariatric surgery-induced weight loss, and whether they depend or not on 25-hydroxyvitamin D (25OHD) status.
Guglielmi, V., Bellia, A., Gentileschi, P., Lombardo, M., D'Adamo, M., Lauro, D., et al. (2018). Parathyroid hormone in surgery-induced weight loss: no glucometabolic effects but potential adaptive response to skeletal loading. ENDOCRINE, 59(2), 288-295 [10.1007/s12020-017-1477-0].
Parathyroid hormone in surgery-induced weight loss: no glucometabolic effects but potential adaptive response to skeletal loading
Guglielmi V.;Bellia A.;Gentileschi P.;Lombardo M.;D'Adamo M.;Lauro D.;Sbraccia P.
2018-01-01
Abstract
Increased parathyroid hormone (PTH) is commonly associated with obesity, and its role in the pathogenesis of obesity-related glucometabolic abnormalities is uncertain. We aimed to explore the relationships of PTH with glucose/insulin homeostasis parameters before and after bariatric surgery-induced weight loss, and whether they depend or not on 25-hydroxyvitamin D (25OHD) status.| File | Dimensione | Formato | |
|---|---|---|---|
|
PTH post-surgery Endocrine 2017.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
584.03 kB
Formato
Adobe PDF
|
584.03 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
